Publisher
Springer International Publishing
Reference46 articles.
1. Stewart KD, Johnston JA, Matza LS, Curtis SE, Havel HA, Sweetana SA, et al. Preference for pharmaceutical formulation and treatment process attributes. Patient Prefer Adherence. 2016;10:1385–99.
2. Alten R, Krüger K, Rellecke J, Schiffner-Rohe J, Behmer O, Schiffhorst G, et al. Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach. Patient Prefer Adherence. 2016;10:2217–28.
3. Quante M, Thate-Waschke I, Schofer M. Was Sind die Gründe der Patientenpräferenz? Vergleich von oraler und subkutaner Darreichungsform [What are the reasons for patient preference? A comparison between oral and subcutaneous administration]. Z Orthop Unfall. 2012;150:397–403.
4. Liu C, Kou Y, Zhang X, Cheng H, Chen X, Mao S. Strategies and industrial perspectives to improve oral absorption of biological macromolecules. Expert Opin Drug Deliv. 2018;15:223–33.
5. Homayun B, Lin X, Choi HJ. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics. 2019;11:129.